Nanolytics Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Nanolytics General Information

Description

Provider of nano-droplet microfluidics. The company provides proprietary novel technologies like microfluidics which can be used for fabricating bio-chips, used for analyzing biological and environmental samples.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Primary Office
  • 5905 Triangle Drive
  • Raleigh, NC 27617
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanolytics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Feb-2007 00000 Completed Generating Revenue
4. Angel (individual) 00000 00000 Completed Generating Revenue
3. Grant 01-Jan-2006 00000 Completed Generating Revenue
2. Grant 01-Jan-2004 $117K Completed Startup
1. Grant 01-Jan-2000 $300K Completed Startup
To view Nanolytics’s complete valuation and funding history, request access »

Nanolytics Executive Team (2)

Name Title Board Seat Contact Info
Alexander Shenderov Ph.D Chief Technology Officer & Co-Founder
Varvara Grichko Ph.D Co-Founder
To view Nanolytics’s complete executive team members history, request access »

Nanolytics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Nanolytics’s complete investors history, request access »